Eucrisa(crisaborole)

Atopic dermatitis (eczema) — PDE4 inhibitor.

1 DTP program
From $158–$223
1 platform

FDA-Approved Indications

Mild-to-moderate atopic dermatitis in patients ≥3 months

Available direct-to-patient (DTP) programs

Sorted by price, lowest first. Always verify eligibility and pricing directly with the manufacturer.

Lowest price option

GoodRx cash program (no insurance required)

via PfizerForAll · Pfizer

$158–$223

GoodRx/Pfizer self-pay: $158.48 (60g, 83% off) / $223.14 (100g, 83% off). Copay card separately: $10/tube for commercially insured.

Eligibility

US residents and Puerto Rico only. Valid Rx required. Cannot combine with other savings. 340B ineligible.

May purchase at cash price. Cannot seek reimbursement or count toward deductible.

Some benefits may not be available in: MA, CA

Visit Program

Last verified: Mar 2026

Not sure which Eucrisa program fits your situation?

Find My Options